On the contrary, Huang et al., 2020 demonstrated that anti-SARS-CoV-2 serum IgA may appear before anti-SARS-CoV-2 IgG and that IgA titer appears higher in patients with severe COVID-19 compared to those with milder illness [31]. The gene discussed is CD79A; the disease is COVID-19.